Type IB variation for application Roszdravnadzor-2021-0099. Type IB variation: Manufacturing Process Change for Atezolimumab-R — minor update

Variation Number
Roszdravnadzor-2021-0099-V299
Type
Type IB
Status
Completed
Fee
€2,727
Submitted
—
Approved
—
Description

Type IB variation: Manufacturing Process Change for Atezolimumab-R — minor update